Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

38.20 USD -1.05 (-2.66%)
Streaming Delayed Price Updated: 2:59 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Glaxosmithkline Plc

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
UPDATE 1-FDA panel backs Glaxo asthma drug for adults, not adolescents
March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma, but not adolescents, an advisory panel to the U.S.... 
Tags companyNews
From Reuters: Company News
FDA panel backs Glaxo asthma drug for adults, not adolescents
March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma but not adolescents, an advisory panel to the U.S.... 
Tags companyNews
From Reuters: Company News
Box nabs US government IT executive
Sonny Hashmi, former CIO of the General Services Administration, will lead Box's efforts to lure government agencies to move to its cloud platform. 
Tags Boston Scientific Corp Business/Technology/Cloud Computing Microsoft Corp
From CNBC.com News
Hottest Healthcare Stocks Now – LLY GSK DGX SHPG
 
Tags Hot Stocks NYSE:HCA NYSE:LLY
From InvestorPlace
FDA panel to discuss Ebola vaccine development in May
March 18 (Reuters) - The U.S. Food and Drug Administration said an advisory panel will discuss the development of Ebola vaccines, days after an American health worker was flown back after being tested... 
Tags companyNews
From Reuters: Company News
Lusitanophones And Other Suspects
The largest sector, natural gas pipelines, did well, but midstream, its current no. 2 business, did poor. 
Tags Stocks / Equities Commodities
From Blogs - TalkMarkets
UPDATE 1-FDA staff finds no new safety problems with Glaxo's asthma drug
March 17 (Reuters) - GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems while being tested to treat asthma, a preliminary review by U.S.... 
Tags companyNews
From Reuters: Company News
FDA staff finds no new safety problems with Glaxo's asthma drug
March 17 (Reuters) - GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems in treating asthma, a preliminary review by U.S. Food and Drug... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Dementia drug research aided by $100 mln venture capital fund
* Backers include British govt, GSK, J&J, Pfizer, Lilly, Biogen 
Tags companyNews
From Reuters: Company News
Dementia drug research aided by $100 mln venture capital fund
LONDON, March 17 (Reuters) - The world's first venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $100 million with the backing of the British government and... 
Tags companyNews
From Reuters: Company News
Ebola booster vaccine trial to combine GSK, Emergent Bio shots
LONDON, March 16 (Reuters) - Scientists are to test a new two-shot Ebola vaccine using an experimental shot from Britain's GlaxoSmithKline, which is already in clinical trials in Africa, and a new kind... 
Tags companyNews
From Reuters: Company News
Week In Review: Porton Fine Chemicals Buys Dongbang Pharma
Porton Fine Chemicals will acquire Jiangxi Dongbang Pharmaceutical Co., Ltd. for $41.5 million. The purchase will be paid with $16 million in cash and the remainder in stock. 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Week in Review: Porton Fine Chemicals Buys Dongbang Pharma
Porton Fine Chemicals of Chongqing will pay $42 million to acquire Jiangxi Dongbang Pharma, combining their CMO API assets; Shanghai Pharma will form a $16 million on-line drug distribution JV with... 
From ChinaBio® Today
Why biotech investors may be hurting innovation
Over the past five years, investor money is increasingly moving towards consumer software and later-stage life science ventures, a trend that could help develop new treatments. 
Tags Johnson & Johnson Business/Mergers and Acquisitions/Venture Capital Eli Lilly and Company
From CNBC.com News
5 Best Countries for ETF Investment
 
Tags NYSE:MCD NYSEARCA:VOOV NYSE:GSK
From InvestorPlace
UPDATE 2-GSK raises $853 mln by halving stake in S.African drugmaker
* British group retains 6.2 percent stake in Aspen (Updates with actual amount raised following sale) 
Tags companyNews
From Reuters: Company News
PRESS DIGEST- Financial Times - March 13
March 13 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
Johnson & Johnson sues Glaxo over allergy ads as spring nears
NEW YORK, March 12 (Reuters) - Johnson & Johnson sued rival drugmaker GlaxoSmithKline PLC on Thursday, alleging that Glaxo is trying to unlawfully grab market share with false advertising at the start... 
Tags companyNews
From Reuters: Company News
UPDATE 1-GSK to pocket $890 mln by halving stake in S.African drugmaker
LONDON, March 12 (Reuters) - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm. 
Tags companyNews
From Reuters: Company News
GSK's big bet: Tapping our body's electronics
GSK expects it can design technology small and smart enough to manipulate our bodies' electrical systems and create new treatments for diseases. 
Tags Politics and Government/Government Agencies/FDA S&P 500 Biogen Idec Inc
From CNBC.com News
Theravance Biopharma Q4 Loss Widens Y/Y, Revenues Up
Theravance Biopharma, Inc. reported fourth-quarter 2014 loss of $2.02 per share, wider than a loss of $1.39 per share incurred a year ago. 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
GSK to Build New Asia Headquarters in Singapore
GlaxoSmithKline announced plans for a larger Asia headquarters in Singapore, where the company currently has its Asia head office. The new space will total about 160,000 square feet and house up to... 
From ChinaBio® Today
2 Biotech Candidates With Massive Buyout Potential
If a large pharma or biotech company is looking to make a major splash in 2015, Vertex Pharmaceuticals could fit the bill. 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
UPDATE 1-Drugmaker GSK to steer Asian business from new Singapore HQ
* New HQ slated for completion in late 2016 (Adds details, CEO comments) 
Tags companyNews
From Reuters: Company News
Drugmaker GSK to steer Asian business from new Singapore HQ
March 11 (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday it was establishing a new global headquarters for Asia in Singapore, strengthening its presence in the city-state. 
Tags companyNews
From Reuters: Company News
The Global Shift
News from various lands (Switzer-, Fin-, Ire-, Nether-) and continents. 
Tags Technology Stocks / Equities Capital & Industrial Goods
From Blogs - TalkMarkets
GSK sacks 110 China staff in wake of drug bribery case - sources
LONDON, March 6 (Reuters) - Drugmaker GlaxoSmithKline , which was fined 3 billion yuan ($479 million) in China last year for bribery, is dismissing 110 employees in the country for misconduct, people... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Merck-NewLink Ebola vaccine Phase III trial to start March 7
GENEVA/LONDON, March 5 (Reuters) - Final stage of testing of an experimental Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization... 
Tags companyNews
From Reuters: Company News
Merck-NewLink Ebola vaccine Phase III trial to start March 7
GENEVA, March 5 (Reuters) - Merck & Co and NewLink Genetics Corp's Ebola vaccine will begin a Phase III trial in Guinea on March 7, the final stage of testing, the World Health Organization said on... 
Tags companyNews
From Reuters: Company News
A New Contest; Understanding India; Global Stock Roundup
What India's new budget means for investors - plus looking for help understanding ST Microelectronics. 
Tags Stocks / Equities Mutual Funds
From Blogs - TalkMarkets
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.